Morphosys: BioEquity Europe (Morphosys) - May 29, 2015 - Anticipated data from P1 trial (NCT01973309) for breast cancer in 2015; Anticipated data from P1 trial (NCT01957007) for NSCLC in 2015; Anticipated data from P1 trial (NCT02005315) for pancreatic cancer in 2015; Anticipated data from P1 trial (NCT01345201) for solid tumors in 2016
Anticipated P1 data • Breast Cancer • Non Small Cell Lung Cancer • Oncology • Pancreatic Cancer
|